Short Interest Don’t Lie: Could CELYAD SA ORD BELGIUM (OTCMKTS:CLYYF) See a Reversal After More Sellers Came In?

November 29, 2016 - By Richard Conner   ·   0 Comments

Short Interest Don't Lie: Could CELYAD SA ORD BELGIUM (OTCMKTS:CLYYF) See a Reversal After More Sellers Came In?

The stock of CELYAD SA ORD BELGIUM (OTCMKTS:CLYYF) registered an increase of 13.53% in short interest. CLYYF’s total short interest was 23,500 shares in November as published by FINRA. Its up 13.53% from 20,700 shares, reported previously. The stock last traded at $22 per share. It is down 6.00% since October 30, 2016 and is uptrending. It has outperformed by 0.74% the S&P500.

More recent CELYAD NPV (OTCMKTS:CLYYF) news were published by: Seekingalpha.com which released: “Celyad: An Unknown Biotech That Will Fix Your Broken Heart” on January 23, 2016. Also Seekingalpha.com published the news titled: “Celyad (CYAD) CEO Christian Homsy on Q4 2015 Results – Earnings Call Transcript” on March 24, 2016. Seekingalpha.com‘s news article titled: “Why Juno Therapeutics Could Be The Future Leader In CAR-T And TCR Immune …” with publication date: September 12, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Richard Conner


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>